Navigation Links
Paper Highlights Antimicrobial Effectiveness of Medical-Grade Honey in Topical Wound Care
Date:7/27/2009

PRINCETON, N.J., July 27 /PRNewswire-FirstCall/ -- A recent paper published in the European Journal of Clinical Microbiological Infectious Diseases details how a certain kind of honey can be an effective agent in topical wound care, particularly where antibiotic resistance is an issue.

Entitled, "The unusual antibacterial activity of medical-grade Leptospermum honey: antibacterial spectrum, resistance and transcriptome analysis," the report describes the palliative effects of Leptospermum honey. Indigenous to New Zealand and Australia, Leptospermum honey possesses unique plant derived components that make it an ideal wound dressing, including novel antimicrobial and immunomodulatory compounds. Among the honey's properties are low pH levels, the ability to help remove non-vital tissue from the wound area, stimulate new tissue growth, and reported reduction in scarring and pain levels.

The paper also describes how medical-grade honey might be a strong combatant against antibiotic resistant pathogens such as MRSA and vancomycin-resistant strains (VRS) and that its use at sub-lethal levels (levels too low to kill bacteria) does not induce resistance. The activity that this particular species of honey demonstrates against typically resistant virulent pathogens, makes medical-grade active Leptospermum honey a compelling option for clinicians in their management of surgical site infections and diabetic foot infections. Equally important is that all these benefits exist without any toxicity to healthy tissue.

MEDIHONEY dressings, a unique line of products containing active Leptospermum honey, provide a moist, occlusive environment conducive to optimal wound healing, enabling them to work effectively in the presence of wound fluid, blood, and tissue, promoting an optimal healing environment. Available in dressings and gel form, MEDIHONEY products, leading brand of New Jersey, USA-based Derma Sciences Inc. (OTC Bulletin Board: DSCI.OB), are indicated for the management of lightly to heavily exuding wounds such as: diabetic foot ulcers, venous stasis leg ulcers, arterial leg ulcers, leg ulcers of mixed etiology, pressure ulcers (I-IV), first and second degree burns, donor sites, traumatic and surgical wounds.

"The data presented here argue for a greater use of medicinal-grade honey in wound care, particularly where antibiotic resistance is an issue," the European Journal of Clinical Microbiological Infectious Diseases paper concludes.

Derma Sciences has strong IP around dressing configurations that include honey, exclusive rights for MEDIHONEY in the Americas, and a partnership with New Zealand-based Comvita, which controls 75% of the Leptospermum honey harvested. Click here to read the complete story.

Contact: Susan Morgenbesser/ IRG/ 212-825-3210/ smorgenbesser@investorrelationsgroup.com


'/>"/>
SOURCE Derma Sciences
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Integrated Healthcare Association Releases White Paper on Pay for Performance
2. Can pen and paper help make electronic medical records better?
3. Tijuana Newspaper, Zeta Tijuana, Releases Detailed List of Day Care Center Owners and Their Total Earnings; Interchildren, Inc. Calls for Newspaper Boycott
4. BurrellesLuce White Paper Gives Advice on Turning Twitter Connections Into Community Building Blocks
5. New White Paper from The Beryl Institute Provides Insights to Generations
6. British Medical Journal Report Supports SCHS White Paper on Statins
7. Pivotal White Paper Examines Retail Industrys Critical Role in Reengineering the Health Care System
8. Renaissance America Tracks Trend on Loss of Retiree Benefits in New Whitepaper
9. Research from Dr. Charles Gerba Finds Average Toilet Paper & Towel Dispensers Have More Bacteria Than Average Toilet Seat
10. Online obituaries are changing the way we publicly remember the dead and how newspapers cover deaths
11. New White Paper Helps OEM Design Engineers Navigate the Force Transducer Selection Process
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for ... $12 an hour by 2020 and then adjusting it yearly to increase at the same ... wage, assure the wage floor does not erode again, and make future increases more predictable. ...
(Date:6/24/2016)... ... 2016 , ... EB Medicine presented its first-ever “Issue of ... in Ponte Vedra Beach, FL. The awards honor the outstanding work of leading ... and Pediatric Emergency Medicine Practice. , “With this award, we recognize the efforts ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... client, The Grove Investment Group (TGIG), has initiated cultivation and processing operations at ... Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of a complete ...
(Date:6/24/2016)... ... June 24, 2016 , ... National recruitment firm Slone Partners ... with extensive sequencing and genomics experience, as Vice President of North American Capital Sales ... be responsible for leading the sales team in the commercialization of the HTG EdgeSeq ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... induced pluripotent stem (iPS) cells and other difficult to transfect cells, announces its ... The PluriQ™ G9™ Gene Editing System is a complete system for ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... The vast majority of dialysis patients currently ... are usually 3 times a week, with treatment times ... time, equipment preparation and wait time.  This regimen can ... patients who are elderly and frail.  Many elderly dialysis ... centers for some duration of time. Residents ...
(Date:6/23/2016)... 2016  Experian Health, the healthcare industry ... patient payment and care experience, today announced ... and services that will enhance the breadth ... These award-winning solutions will enable healthcare professionals ... in an ever-changing environment and redefine front-office ...
(Date:6/23/2016)... , June 23, 2016  The National Pharmaceutical ... joined the health policy research organization as its ... , MD, senior vice president and chief scientific ... representative on the NPC Board of Directors. ... that Mallinckrodt has joined us in support of ...
Breaking Medicine Technology: